Boston Metal is most of the way to a $60m target for its latest round, thanks to a consortium that included returning backer The Engine.

University of Oxford’s autonomous driving software developer Oxbotica has secured $47m in a series B round featuring IP Group as well as several corporates.

Utec has made its largest initial commitment to date by backing Keio-founded Metcela, a developer of cell therapies for heart disease.

Bristol Myers Squibb participated in a series B round for the oncology drug developer that pushed its overall funding to $168m.

The heart disease therapy developer completed a $12.7m round that included Alfresa, Dai-ichi Life, Sony Innovation Fund and Japan Lifeline.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Meituan Dianping and New Hope Group have both thrown their backing behind a round topping $100m for production automation robot developer Flexiv.

Investors have thrown their backing behind a round topping $100m for Stanford-linked production automation robot developer Flexiv.

Legend Star and CMB International are among the participants in the cancer drug developer’s latest round, which was led by Tsing Song Capital.

The SFC-backed vaccine developer has wrapped up its series B-2 round after holding an initial close in early 2019.